Pediatric Primary Care (122 page)

Read Pediatric Primary Care Online

Authors: Beth Richardson

Tags: #Medical, #Nursing, #General

BOOK: Pediatric Primary Care
9.04Mb size Format: txt, pdf, ePub
b.  Iron chelation therapy—transfusions can lead to a build up of iron in the blood.
•  Deferoxamine—liquid given slowly under the skin with a pump; takes time and is often painful and side effects include loss of vision and hearing.
•  Deferasirox—pill taken once a day; side effects include headache, nausea, vomiting, diarrhea, joint pain, and fatigue.
c.  Folic acid supplements—a B vitamin that helps build healthy RBCs.
d.  Bone marrow/stem cell transplant—only cure for thalassemia.
I.  Follow up.
1.  Well-child physical as indicated.
2.  Vaccines as scheduled.
3.  Follow with hematology physicians on routine basis.
J.  Complications.
1.  Heart disease—caused by iron overload from the transfusions.
2.  Heart attack.
3.  Arrhythmias.
4.  Heart failure.
5.  Liver disease—also caused by iron overload and damage to the organ.
6.  Infection—risk of infection higher in persons whose spleen has been removed.
7.  Osteoporosis.
K.  Education.
1.  Follow the treatment plan as outlined by the doctor/clinic.
a.  Blood transfusions as needed.
b.  Chelation medications to be taken as prescribed.
c.  Take your folic acid supplements.
2.  Routine maintenance.
a.  Yearly well child checks (WCC).
•  Height and weight.
•  Test for iron build up in the liver.
•  Vision and hearing tests.
b.  Monthly CBCs.
c.  Quarterly tests for iron build up in the blood.
3.  Measures to stay healthy.
a.  Healthy eating.
b.  Vaccinations as scheduled.
c.  Watch for signs of infection.
d.  Wash hands.
e.  Avoid crowds during cold and flu season.
f.  Call clinic/doctor if develop fever.
4.  Support groups—parents and children.
III.  LEAD POISONING
 
Headache, 784
Poor attention span, 314
Irritability, 799
Seizures, 780.39
Lead poisoning, 984.9
Sleep disorders, 780.5
Loss of visual motor coordination, 781.3
Stomachache, 789
Muscular weakness, 728.87
Tiredness, 780.79
Poor appetite, 783
Weight loss, 783.2
 
A.  Most common, widespread environmental health concern, especially for children younger than 6 years of age. Can cause decrease in gestational weight and age; may increase possibility of stillbirths and miscarriages.
B.  Etiology.
1.  Increased lead levels in children occur by exposure to deteriorating paint, household dust, bare soil, air, drinking water, food, ceramics, home remedies, hair dyes, other cosmetics. Usually exposure is in child's own home.
2.  Manufacture, use, disposal of modern products containing lead results in fine lead particles that release into environment. Lead particles enter air, water, food; also contaminate soil, dust.
3.  Lead containing toys, crayons, soft vinyl lunch boxes.
C.  Occurrence.
1.  Estimated at least 400,000 children younger than 6 years of age have too much lead in their bodies.
2.  Questions for assessing risk of lead poisoning:
a.  Live in, regularly visit, or have lived in a place with peeling or chipping paint built before 1960?
•  Includes daycare, preschools, homes of babysitters, relatives.
•  Houses with recent, ongoing, planned renovation or remodeling.
b.  Brother or sister, housemate, playmate being followed or treated for lead poisoning (blood level > 15 mcg/dL)?
c.  Live with adult whose job or hobby involves exposure to lead?
•  Ceramics, furniture refinishing; stained glass work; construction workers.
d.  Taking home remedies such as azarcon and greta?
e.  Live near active smelter, battery-recycling plant, other industry likely to release lead into air?
3.  Lead toxicity is decreasing in the United States but approximately 25% of children still live in housing with deteriorating lead-based paint.
D.  Clinical manifestations.
1.  Many symptoms resemble common childhood complaints: headache, stomachache, irritability, tiredness, poor appetite.
2.  Other subtle symptoms: poor attention span and memory, sleep disorders.
3.  All of these can lead to coma and death because not noticed until brain damage has already occurred. Once organ systems are damaged, damage often irreversible.
E.  Physical findings.
1.  Weight loss, decreased growth.
2.  Muscular weakness (diminished reflexes).
3.  Seizures (signs of anemia).
4.  Loss of visual motor coordination.
5.  Irritability.
6.  Constipation, abdominal pain.
7.  Learning difficulties/cognitive impairment.
F.  Diagnostic tests.
1.  CBC.
2.  Lead blood levels: < 10 mcg/dL. Screening tests as recommended by Centers for Disease Control and Prevention (CDC)
(
Table 32-2
).
3.  Free erythrocyte protoporphyrin (FEP): elevated.
Table 32-2
CDC Recommendations for Follow-Up Lead Blood Level Measurements
Class
Blood lead level
Comment
I
≤ 9 mcg/dL
Not lead poisoned
 
 
Low risk: 6–35 months of age, retest at 24 months
 
 
High risk: 6–35 months of age, retest every 6 months
 
 
Older than 36 months of age: retest yearly until 6 years of age
 
 
IIA
10–14 mcg/dL
Rescreen frequently and consider prevention activities 6–35 months of age, retest every 3–4 months
 
 
Older than 36 months of age, retest yearly
 
 
IIB
15–19 mcg/dL
Institute nutritional and educational interventions
 
 
Retest every 3–4 months
 
 
III
20–44 mcg/dL
Evaluate environment and consider chelation therapy
 
 
Retest every 3–4 months
 
 
IV
45–69 mcg/dL
Institute environmental intervention and chelation therapy within 48 hours
 
 
V
< 70 mcg/dL
Medical emergency; requires immediate treatment
 
 

Source:
Data from Centers for Disease Control and Prevention. Recommendations for follow-up lead blood level measurements. Retrieved March 2004, from:
www.cdc.gov
; Cohen, S. (2001). Lead poisoning: A summary of treatment and prevention.
Pediatric Nursing
, 27, 125.

G.  Differential diagnosis.
 
Abdominal pain, unspecifi ed, 789
Iron-deficiency anemia, 280.9
Behavioral disorders, 312.9
Unexplained seizures, 780.39
 
1.  Neurologic problems (unexplained seizures, behavioral disorders).
2.  IDA.
3.  Unexplained abdominal pain.
H.  Treatment.
1.  Lead blood level determines treatment (
Table 32-2
).
2.  Alteration in environment; stop unusual exposure to lead.
3.  Good nutrition.
4.  Chelation therapy.
a.  British anti-Lewisite (BAL).
b.  Edetate calcium disodium (CaNa2EDTA).
c.  Dimercaptosuccinic acid (DMSA) or Succimer.
d.  
D
-Penicillamine.

Other books

The Alpine Recluse by Mary Daheim
Assata: An Autobiography by Assata Shakur
Centralia by Mike Dellosso
Bring Him Back by Scott Mariani
Bloodmark by Whittet, Aurora
Unspeakable by Sandra Brown
Bad Boy Dom by Holly Roberts